Background
==========

The need for continuing medical education (CME) as a part of a medical doctor\'s professional development has been recognized all over the world \[[@B1],[@B2]\]. Since 1991, CME has been compulsory for all Iranian physicians and other health professionals.

Traditionally, general physicians working in primary care as general practitioners (here referred to as GPs) have obtained their CME through lectures and written materials. These methods may increase their knowledge, but there is no clear evidence that their skills or performance are impacted \[[@B3]-[@B9]\].

Although outcome-based education (OBE) initially was proposed for undergraduate medical education and training \[[@B10]\], it is now increasingly recognized as a useful approach for CME \[[@B11]\]. OBE can influence the entire process of education, i.e. decisions about the content, formulation of aims, educational strategies, the teaching methods, the assessment procedures and the educational environment \[[@B10]\].

Several advantages have been suggested for adopting an OBE model for medical education, such as helping to increase the relevance of the education to the future practice of medicine. OBE allows for a wide degree of participation in the curriculum design process as well as flexibility regarding the choice of educational strategies used. OBE appears to be acceptable to most teachers probably because the concepts of OBE are clear, easily understandable, and provide a robust framework for the curriculum \[[@B10],[@B12]\].

Recent studies of CME for physicians in Iran show that modifications of CME elements are necessary to improve the effectiveness of the educational programs \[[@B13],[@B14]\]. There are also convincing data showing excessive prescribing behaviour in Iran among GPs \[[@B15]\]. Some studies point to an inappropriate, even irrational drug prescribing \[[@B16],[@B17]\]. According to an unpublished needs assessment study about CME for GPs in the East Azerbaijan province in Iran (2002), rational prescribing practice was recognized as a high priority issue.

Given the timeliness and importance of this issue in Iran, we are conducting a project aimed at evaluating the effectiveness of using OBE on GPs knowledge, skills, attitudes, and performance in a CME program on rational prescribing. No studies on OBE indicators for rational prescribing were found in the literature. The aim of this study was, therefore, to identify the appropriate outcomes and indicators for rational prescribing based on expert opinions and developing the curricular content in a CME program for GPs.

Methods
=======

The study was conducted between October 2005 and July 2006 in three phases. The first phase consisted of two rounds of a Delphi process. In the second phase, panel discussion sessions were used to further clarify, reach consensus, and then prioritize the learning outcomes and indicators. Finally, an appointed team determined content for the CME programme.

The Delphi technique was originally conceived of as a way to obtain the opinion of experts without necessarily bringing them together face to face \[[@B18]\]. This is what attracted us to the method. For our study, we used a modified version of the technique which also involved panel discussions with experts in the field of rational prescribing and CME. In the first two phases, the methodology was similar to what has been described previously \[[@B12],[@B19]\].

A questionnaire was designed consisting of potential learning outcomes identified from a range of sources: WHO (World Health Organization) prescribing indicators \[[@B20],[@B21]\], relevant documents \[[@B16],[@B17],[@B22],[@B23]\], and topics covered by CME programs on prescribing in Iran. A small group of experts (a pharmacologist, a pharmacist, and two medical specialists) assisted the research team in defining a preliminary list of 16 potential outcomes with appropriate measurement indicators for each one.

Participants
------------

We selected 30 stakeholders who had a background from at least one of the following categories (some represented several categories): 1) seven experienced GPs, 2) four CME decision makers from Iranian medical science universities with a background in pharmacy, pharmacology, or health management and who work for the Ministry of Health and Medical Education (MOHME), 3) nine pharmacists, 4) seven pharmacologists, 5) six medical specialists. With the exception of the experienced GPs, all the participants were faculty members of four of the Universities of Medical Sciences in Iran as well as being CME trainers.

Delphi process and panel discussion
-----------------------------------

The questionnaire, with the 16 potential outcomes including a definition of each outcome (to avoid any misunderstanding), was sent out to the participants. The respondents were asked if there was a need to include the outcome in a programme on rational prescribing. They answered using a 5-point Likert scale (1 = totally agree, 2 = partly agree, 3 = uncertain, 4 = partly disagree and 5 = totally disagree). They were also asked to suggest any other potential learning outcomes, based on their expertise in the area.

The results of the returned questionnaires were assessed by the research team and a second questionnaire was developed for the next stage of the Delphi process. It consisted of the initial potential learning outcomes from round 1 and ten new learning outcomes that had been suggested by the experts. In this round, each member of the study was asked to determine which of the proposed outcomes should be included by using a 4-point scale (1 = totally agree, 2 = partly agree, 3 = partly disagree and 4 = totally disagree) to avoid uncertain answers.

The questionnaire responses were coded and frequencies were determined using Microsoft Excel 2003 \[[@B24]\]. The results of the second stage of the Delphi process were submitted to a specially assigned panel of experts comprised of four CME decision-makers, four pharmacists or pharmacologists, four medical specialists, three GPs, one epidemiologist, and the first author. The task of the panel was to reach consensus on the final educational outcomes and indicators and to identify a suitable team of experts to develop the content.

Developing the content
----------------------

The team responsible for content development was comprised of seven experienced CME trainers, all who had participated in the panel discussion, and the first author. They identified educational topics for an outcome-based CME program in rational prescribing informed by the list of outcomes and outcome indicators that were developed from the second Delphi round. To each of these topics a small group of experts and CME trainers was assigned, with the task of developing the curricular content for that topic.

The results from each of the small groups were distributed to all the other teams one week prior to a final review meeting. At this meeting, ideas about the curricular content were discussed and consensus was reached after a revision of some of the topics. The final curricular content formed the basis for the OBE educational program that was to be used in the CME program on Rational Prescribing.

Ethical approval for the study was received from the Ethical Vetting Committee of the Iranian Ministry of Health and Medical Education. Informed consent was given through agreeing to participate in the different phases of the study.

Results
=======

The Delphi process
------------------

Completed questionnaires were returned from 21 of the 30 participants in the first round. Nine of the participants (four medical specialists, two pharmacologists and three pharmacists) did not answer, despite the reminder we sent out one month later. These non-responders were contacted by e-mail and/or telephone; six replied that they were too busy to answer and three did not wish to participate as they saw no personal benefit.

Ten new potential outcomes were added in the second round based on the experts\' suggestions. The second questionnaire was sent to the 21 experts who had answered in the first round. All but one responded with new ratings. Table [1](#T1){ref-type="table"} displays both the original outcomes and the ones suggested by the participants in round 1. Some suggestions were deemed to be beyond the scope of the programme (such as the importance of using a computerized prescription system to remedy prescribing errors and the importance of the influence of socio-economic factors on rational prescribing) or in conflict with course aims (for instance, criticisms about using the generic names of drugs) and therefore excluded from the process.

###### 

Potential learning outcomes as assessed through the Delphi process

  **Potential outcomes for Rational Prescribing (round 1)**                                                           **Agreement\* (n = 21)**   **Agreement\* (n = 20)**
  ------------------------------------------------------------------------------------------------------------------- -------------------------- --------------------------
  *Upon completion of the course, a doctor will be able to write a prescription that includes or considers:*          **Round 1**                **Round 2**
                                                                                                                                                 
  1\. Date of the prescription                                                                                        21                         20
  2\. Name and age of the patient                                                                                     21                         20
  3\. Name and identification number of Iranian Medical Council of the prescriber\*\*                                 21                         20
  4\. Main complaint of the patient                                                                                   11                         16
  5\. Legible hand writing                                                                                            20                         20
  6\. Generic name of the drugs                                                                                       16                         18
  7\. Administration form of drugs                                                                                    20                         20
  8\. Strength of the drugs and dose frequency                                                                        20                         20
  9\. Adequate duration of treatment                                                                                  16                         20
  10\. Latin abbreviation of terminology in drug use order                                                            12                         17
  11\. Appropriate number of drugs                                                                                    16                         20
  12\. To consider homogeneity of prescription per individual (all drugs prescribed pertain to the same individual)   18                         19
  13\. Not prescribing drugs with the same pharmacological effect                                                     14                         19
  14\. Not prescribing drugs which have negative interactions with each other                                         17                         19
  15\. Appropriate number and amount of antibiotics                                                                   19                         20
  16\. Appropriate number of injections                                                                               17                         20
                                                                                                                                                 
  **Suggested potential outcomes (added in round 2)**                                                                                            
  1\. Contact telephone number of the prescriber                                                                                                 17
  2\. Refill information                                                                                                                         18
  3\. Initial diagnosis                                                                                                                          15
  4\. Time and manner of drug use                                                                                                                17
  5\. Necessary precautions                                                                                                                      16
  6\. Necessary notifications about signals to continue or stop drug use                                                                         13
  7\. Notification about side effects of drugs in the prescription                                                                               6
  8\. Name of the foods which have negative interactions on drug efficacy and the treatment process                                              8
  9\. Appropriate no. of NSAID (Non-steroidal anti-inflammatory) drugs                                                                           20
  10\. Appropriate number of vitamins                                                                                                            19

\* Sum of the number of respondents who answered \"partly agree\" and \"totally agree\".

\*\* Compulsory in Iran

The panel discussion
--------------------

The panellists finalised the learning outcomes during two meetings based on the results of the Delphi process. They agreed to accept all outcomes which at least four out of five experts had agreed to. However, two outcomes (\"Writing main complaint of the patient in the prescription\" and \"Appropriate number of vitamins\") were eliminated and a part of the last outcome was expanded to include corticosteroids. Some of the experts were critical about using generic names because of the specific opinions that both doctors and patients can have regarding different brands. However, citing the WHO, it was suggested that this can be solved by adding the trade name after the generic name if there is a particular reason to prescribe a specific brand \[[@B21]\]. At the end of the second meeting, 21 learning outcomes and appropriate assessment indicators had been identified (Table [2](#T2){ref-type="table"}).

###### 

Rational prescribing outcomes and indicators for GP\'s CME programmes as agreed by an expert panel

  **Outcomes**                                                                                                                              **Assessment Indicator**
  ----------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------
  *Upon completion of the course, a participant should be able to:*                                                                         
  1\. Write the date of the prescription                                                                                                    1\. Date of the prescription
  2\. Write the name of the patient                                                                                                         2\. Name of the patient
  3\. Write the age of the patient                                                                                                          3\. Age of the patient
  4\. Write the name and identification number of the Iranian Medical Council for the prescriber                                            4\. Name and identification number of Iranian Medical Council of the prescriber
  5\. Write the contact telephone number of prescriber                                                                                      5\. Contact telephone number of prescriber
  6\. Write refill information                                                                                                              6\. Refill information
  7\. Write the prescription clearly                                                                                                        7\. Legible hand writing
  8\. Write the generic name of the drugs                                                                                                   8\. Generic names of drugs
  9\. Write the administration form of the drugs                                                                                            9\. Administration form of drugs
  10\. Write the strength of the drugs (dose and dose frequency)                                                                            10\. Strength of the drugs
  11\. Write the duration of treatment                                                                                                      11\. Treatment duration
  12\. Use the Latin abbreviation of terminology in drug use order                                                                          12\. Use Latin abbreviation terminology
  13\. Write the time and manner of drug use                                                                                                13\. Time and manner of drug use
  14\. Write the necessary precautions                                                                                                      14\. Necessary precautions
  15\. Prescribe the appropriate number of drugs                                                                                            15\. Appropriate number of drugs
  16\. Consider homogeneity of prescription per individual (all drugs prescribed pertain to the same individual)                            16\. Homogeneity of prescriptions
  17\. Avoid prescribing drugs with the same pharmacological effect                                                                         17\. Number of drugs in the same pharmacological group
  18\. Avoid prescribing drugs which have negative interactions with each other                                                             18\. Number of interactive drugs per prescription
  19\. Prescribe the appropriate number and amount of antibiotics                                                                           19\. Number and amount of antibiotics per prescription and proportion of antibiotics prescribed
  20\. Prescribe the appropriate number of injections                                                                                       20\. Number of injections per prescription and proportion of injections prescribed
  21\. Prescribe the appropriate number of Anti-Inflammatory Agents \[Corticosteroids and Non-steroidal anti-inflammatory drugs (NSAID)\]   21\. Appropriate number of Anti-Inflammatory Agents \[Corticosteroids and Non-steroidal anti-inflammatory drugs (NSAID)\]

Content development
-------------------

In the third phase, the team responsible for content development divided the 21 learning outcomes into six main areas for the educational programme: 1) Principles of prescription writing, 2) Adverse drug reactions (ADR), 3) Drug interactions, 4) Injections, 5) Antibiotic therapy, and 6) Anti-inflammatory agents therapy

The content for each of these six topics was then developed individually by six small teams of professionals who were experts in each topic. The curricula were distributed and validated by all participants in the final meeting, during which the content was finalized (Table [3](#T3){ref-type="table"}).

###### 

Curricular content for the programme on rational prescribing as developed by teams of CME trainers.

  **Topics for the rational prescribing curriculum**   
  ---------------------------------------------------- ------------------------------------------------
  **1-Principles of prescription writing (1--16)\***   **5-Antibiotic therapy (19)**
  History of prescription writing                      Value of taking culture samples for infections
  Classification of drugs                              Assessment of infectious organisms
  Definition and format                                Importance of host factors in selection of
  Elements of prescription writing                     antibiotics
  Measurements                                         Adherence to correct indications
  Mistakes and errors in prescription writing          Selection of antibacterial drug(s)
  Abbreviations                                        Important factors for choosing form, dose and
  Poor prescriptions                                   course of antibiotics
  Rational prescriptions                               Importance of switching antibiotics based on
  **2-Adverse reactions to drugs**                     culture and antibiogram results
  Background                                           Pharmacology of antibiotic groups:
  Epidemiology                                         ○ Betalactamases
  Etiology                                             ○ Tetracyclines
  Exaggeration of an intended pharmacologic            ○ Aminoglycosides
  action of the drugs                                  ○ Macrolides
  Toxicity unrelated to a drug\'s primary              ○ Fluoroquinolones
  pharmacological activity:                            ○ Sulfonamides
  \- Cytotoxic Reactions                               **6- Anti-inflammatory agents therapy (21)**
  \- Immunologic Mechanisms                            A\) Corticosteroids
  Diagnosis and treatment of adverse drug              Indications
  reactions                                            Emphasis on reducing injections
  **3- Drug Interactions (17, 18)**                    Adverse effects
  Important mechanisms of drug interactions            Important interactions
  Common drug interactions in the practice of          B\) Non steroidal anti inflammatory drugs
  general physicians                                   (NSAIDs)
  **4- Injections (20)**                               Indications
  Consideration of real needs for prescribing          Adverse effects
  injections                                           Drug Interactions
  Mechanism of injections                              Contraindications
  Indications for injections                           
  Important factors in prescribing injections          
  Prevalence of prescribing injections in the          
  world and in Iran                                    

\* Numbers in parentheses refer to the related outcomes.

Discussion
==========

The Delphi technique was chosen in order to distil the opinions of several experts and reach consensus without geographical constraints \[[@B25]\] and with heterogenic groups \[[@B26]\]. A panel of selected experts has been used in other Delphi studies to identify prescribing errors in order to increase the validity of the findings \[[@B27],[@B28]\]. We used a modified version with panel discussions and small working groups in order to better validate the results, minimize ambiguity, and further develop program content. The process yielded twenty-one outcomes and their related indicators. These included all but one of the initially proposed indicators and half of the additionally suggested ones (the indicator for name and age was divided into two separate ones to make it easier to assess). Based on discussions about the outcomes, six topic areas were identified and curricular content for each was determined by an expert team based on these outcomes. The content was then validated by all the participating experts.

We began the Delphi process by creating a preliminary list of potential learning outcomes through a literature review and then made use of experts\' opinions to develop and prioritize these outcomes. These experts were involved in CME either as decision makers or trainers. GPs representing the target audience were also included as a way of improving the relevancy of the programme as has been described previously \[[@B9]\]. In these ways, we aimed to bridge the gap between the actual learning needs of individual practitioners and the educational content that is considered to meet assumed needs, a problem that has been described in the educational literature \[[@B29],[@B30]\].

Two of the learning outcomes which were suggested by the experts during the Delphi process were excluded during the panel discussions. Due to a concern that the CME programme as a whole would be rejected if individual parts were considered to be too controversial, the outcome \"writing main complaints of the patient in the prescription\" was rejected. The panellists thought that it would be too great a departure from the current work practice of physicians. Even though the over prescribing of vitamins is thought to be a problem in Iran, the outcome, \"appropriate number of vitamins\", was rejected since it would be difficult to assess as most vitamins are not reimbursed by insurance organizations, the registries of which provide the best way to assess physician prescribing behaviour in Iran.

The panel added one outcome related to the prescribing of corticosteroids as it had been reported that corticosteroid drugs had been prescribed more than any other drug group in East Azerbaijan Province during the last year (yearly report of Rational Prescribing Committee, Tabriz University of Medical Sciences, Tabriz, Iran; 2005). The panel also emphasized the importance of the learning outcomes related to instructions on how to administer medications as there is evidence that there is a large number of prescriptions that do not include directions for patient use \[[@B16]\]. These were two examples, where outcomes from the original Delphi process were further modified or built upon with the modified Delphi process.

A comparison of the outcomes with the curricular content of the course that was developed reveals that while all of the outcomes are covered in the course, the entire course is not covered by the outcomes as the topic \"adverse reactions to drugs\" is not directly related to an outcome. ADR can be the result of irrational prescribing. Thus, knowledge about the consequences of irrational prescribing can motivate a change in participants\' behaviour. As such, ADR can be considered integral to a course on rational prescribing. However, if the course was supposed to be designed using an OBE approach, why wasn\'t ADR identified as an outcome? Possible explanations are on the one hand that tradition prevailed and on the other that the specific construction of the task for the Delphi rounds had a decisive influence.

Regarding the first explanation, a review of the topics that were included in the curricula shows that these topics were taught in other CME courses on prescribing. Since the team of experts responsible for content development all had taught according to the earlier curricula, tradition might have prevailed despite receiving the finalized list of outcomes and an explanation about how they were derived.

The other more distinct and plausible explanation for why the initial Delphi process did not elicit a topic that content developers deemed essential could be due to the formulation of the instructions for the Delphi process. The task was to identify what should be included or considered when the doctor writes a prescription. We believe this to be the main reason for not suggesting ADR as an outcome indicator as information on ADR cannot be written directly in the prescription. However, since ADR has to be considered before a particular drug is chosen, content developers included this topic in the curriculum. While it would have been possible to develop direct outcomes and indicators for ADR, ADR can be seen to indirectly be part of and important in achieving some of the other outcomes, such as avoiding prescribing drugs with negative interactions or similar effects or prescribing injections too frequently.

A final observation was that the constructive alignment approach \[[@B31]\], where outcomes are tied together with content and assessment methods, was not expressly discussed during the third phase of content development. This could mean that content developers were simply unaware of the need to explicitly link outcomes to course content and could thus benefit from more knowledge about outcome-based education and constructive alignment prior to designing courses.

Another question concerns the quality of the outcomes and the indicators that were formulated. Outcomes can be analyzed based on how specific they are, if they are measurable, if they cover the domains of knowledge, skills, and attitudes, and if they are of a manageable number \[[@B32]\]. Most of the outcomes meet these criteria. However, the word \"appropriate\" (found in outcomes 15 and 19--21) is harder to measure, although it would be possible to measure if linked to clear guidelines. According to the ideas behind outcome-based education and constructive alignment, the validated indicators could form the basis for assessment of GPs\' performance and provide them with feedback on the effectiveness of their learning. This could be pursued in further research.

Conclusion
==========

The modified Delphi process was effective in developing outcomes and indicators that were then used in the development of content for a course in rational prescribing. The indicators can be used to assess what participants have learned during the course as well as prescribing behaviour after the course. To improve the constructive alignment of the course, course developers should understand that outcomes need to be explicitly related to course curricula.
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